Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Size: px
Start display at page:

Download "Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes"

Transcription

1 28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and the 2016/17 Invitation to Tender, d 3 November Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/ Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted. Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes Please note that for any changes (price change, size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12 th of the month prior to the of subsidy change. More information and NOPC forms can be found on our website Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand ( and that a CTPP code has been obtained from the New Zealand Universal List of Medicines ( Pharmacodes and CTPP codes must be provided to PHARMAC by the 5 th of the month prior to the of listing, or 10 business days following the market notification (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode. A Page 1 of 15

2 2015/16 Tender Sole Subsidised Supply Status or Status applies until 30 June 2019 Hospital pharmaceutical tenders Section H of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where no brand is listed. The decisions were as follows: Chemical name Pack Price Listing Status Noradrenaline Inj 1 mg per ml, 4 ml ampoule; 10 $ Noradrenaline BNM (Boucher) 2016/17 Tender Sole Subsidised Supply Status or Status applies until 30 June 2020 Community pharmaceutical tenders Section B of the Pharmaceutical Schedule 2. Tenders awarded to currently listed pharmaceuticals where no other brand is listed. The decisions were as follows: Chemical name Acetazolamide Tab 250 mg; 100 tablets, bottle subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply $17.03 $17.03 Diamox (Arrow) Acitretin Cap 10 mg; 60 tablets, blister $17.86 $17.86 Novatretin (Douglas) Acitretin Cap 25 mg; 60 tablets, blister $41.36 $41.36 Novatretin (Douglas) Amlodipine Tab 2.5 mg; 100 tablets, bottle $2.21 $1.72 Apo Amlodipine Amlodipine Tab 5 mg; 250 tablets, bottle $5.04 $3.33 Apo Amlodipine Amlodipine Tab 10 mg; 250 tablets, bottle $7.21 $4.40 Apo Amlodipine Amorolfine Nail soln 5%; 5 ml OP bottle $19.95 $15.95 MycoNail (AFT) Amoxicillin Inj 250 mg vial; 10 vials $10.67 $10.67 Ibiamox (Douglas) A Page 2 of 15

3 Chemical name subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply Amoxicillin Inj 500 mg vial; 10 vials $12.41 $12.41 Ibiamox (Douglas) Amoxicillin Inj 1 g vial; 10 vials $17.29 $17.29 Ibiamox (Douglas) Amoxicillin with clavulanic acid Tab 500 mg with clavulanic acid 125 mg; 20 tablets, blister $1.95 $1.88 Augmentin (GlaxoSmithKline) 1 August November 2017 Atropine sulphate Eye drops 1%; 15 ml OP bottle $17.36 $17.36 Atropt (Aspen) Benzylpenicillin sodium [Penicillin G] Betahistine di Bupropion Inj 600 mg (1 million units) vial; 10 vials $10.35 $10.35 Sandoz (Novartis) Tab 16 mg; 84 tablets, blister $4.95 $2.89 Vergo 16 (Mylan) Tab modified release 150 mg; 30 tablets, blister $11.00 $11.00 Zyban (GlaxoSmithKline) 1 April July 2017 Calcipotriol Oint 50 mcg per g; 100 g OP tube $45.00 $45.00 Daivonex (Leo Pharma) 1 May August 2017 Cefazolin Inj 500 mg vial; 5 vials $3.99 $3.39 AFT (AFT) Cefazolin Inj 1 g vial; 5 vials $3.38 $3.29 AFT (AFT) Ciprofloxacin Tab 250 mg; 28 tablets, blister $1.75 $1.45 Cipflox (Mylan) Ciprofloxacin Tab 500 mg; 28 tablets, blister $2.00 $1.99 Cipflox (Mylan) Ciprofloxacin Tab 750 mg; 28 tablets, blister $3.75 $3.15 Cipflox (Mylan) Cyproterone acetate with ethinyloestradiol Tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tablets; 168 tablets, blister $5.36 $4.67 Ginet (Rex Medical) Darunavir Tab 400 mg; 60 tablets, bottle $ $ Prezista (Janssen Cilag) 1 April July 2017 Darunavir Tab 600 mg; 60 tablets, bottle $1, $ Prezista (Janssen Cilag) 1 April July 2017 Docusate sodium Tab 50 mg; 100 tablets, bottle $2.31 $2.31 Coloxyl (Aspen) Docusate sodium Donepezil Tab 120 mg; 100 tablets, bottle Tab 5 mg; 90 tablets, blister $5.48 $4.34 $3.13 $3.13 Coloxyl (Aspen) Donepezil Rex (Rex Medical) A Page 3 of 15

4 Chemical name Donepezil subsidy (and price) New subsidy (and price) Tab 10 mg; 90 tablets, blister $10.51 $6.64 Sole supply brand (Supplier) Donepezil Rex (Rex Medical) Date of subsidy change Sole Subsidised Supply Doxazosin Tab 2 mg; 500 tablets, bottle $6.75 $6.75 Apo Doxazosin Doxazosin Tab 4 mg; 500 tablets, bottle $9.67 $9.09 Apo Doxazosin Fusidic acid Tab 250 mg; 12 tablets, blister $34.50 $34.50 Fucidin (Leo Pharma) 1 April July 2017 Gliclazide Tab 80 mg; 500 tablets, bottle $11.50 $10.29 Glizide (Mylan) Glycerol Liquid; 500 ml, bottle $3.71 $3.28 healthe Glycerol BP (Jaychem) Hydrocortisone Powder; 25 g bottle $59.50 $49.95 ABM (ABM) Hydrocortisone and paraffin liquid and lanolin Isosorbide mononitrate Lotn 1% with paraffin liquid 15.9% and lanolin 0.6%; 250 ml, bottle Tab long acting 60 mg; 90 tablets, blister $10.57 $10.57 DP Lotion HC (Douglas) $8.49 $8.29 Duride (Mylan) Ketoconazole Shampoo 2%; 100 ml OP bottle $2.99 $2.99 Sebizole (Douglas) Lopinavir with ritonavir Tab 200 mg with ritonavir 50 mg; 120 tablets, bottle $ $ Kaletra (AbbVie) Losartan potassium Tab 12.5 mg; 84 tablets, blister $1.55 $1.39 Losartan Actavis 1 September December 2017 Losartan potassium Tab 25 mg; 84 tablets, blister $1.90 $1.63 Losartan Actavis 1 September December 2017 Losartan potassium Tab 50 mg; 84 tablets, blister $2.25 $2.00 Losartan Actavis 1 September December 2017 Losartan potassium Tab 100 mg; 84 tablets, blister $2.60 $2.31 Losartan Actavis 1 September December 2017 Magnesium sulphate Inj 2 mmol per ml, 5 ml ampoule; 10 Methotrexate Inj 100 mg per ml, 50 ml vial; 1 vial $99.99 $79.99 Miconazole nitrate Vaginal crm 2% with applicator; 40 g OP tube $12.65 $10.21 DBL (Pfizer) Methotrexate Ebewe (Novartis) $3.95 $3.88 Micreme (Mylan) Morphine sulphate Tab immediate release 10 mg; 10 $2.80 $2.80 Sevredol (MundiPharma) A Page 4 of 15

5 Chemical name subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of subsidy change Sole Subsidised Supply tablets, blister Morphine sulphate Naltrexone Olanzapine Olanzapine Tab immediate release 20 mg; 10 tablets, blister $5.52 $5.52 Sevredol (MundiPharma) Tab 50 mg; 30 tablets, blister $ $ Naltraccord Tab orodispersible 5 mg; 28 tablets, blister Tab orodispersible 10 mg; 28 tablets, blister $1.75 $1.25 Zypine ODT (Mylan) $3.05 $2.05 Zypine ODT (Mylan) Olanzapine Tab 2.5 mg; 28 tablets blister $0.75 $0.64 Zypine (Mylan) Olanzapine Tab 5 mg; 28 tablets, blister $1.65 $1.15 Zypine (Mylan) Olanzapine Tab 10 mg; 28 tablets, blister $2.55 $1.65 Zypine (Mylan) Oxazepam Tab 10 mg; 100 tablets, bottle $6.17 $6.17 Ox Pam (Douglas) Oxazepam Tab 15 mg; 100 tablets, bottle $8.53 $8.53 Ox Pam (Douglas) Pamidronate disodium Pamidronate disodium Pamidronate disodium Paracetamol with codeine Inj 3 mg per ml, 10 ml vial; 1 vial $6.80 $5.98 Pamisol (Pfizer) Inj 6 mg per ml, 10 ml vial; 1 vial $13.20 $15.02 Pamisol (Pfizer) Inj 9 mg per ml, 10 ml vial; 1 vial $19.20 $17.05 Pamisol (Pfizer) Tab paracetamol 500 mg with codeine phosphate 8 mg; 1,000 tablets, blister $21.06 $18.21 Paracetamol + Codeine (Relieve) (Mylan) Perindopril Tab 2 mg; 30 tablets, blister $3.75 $3.75 Apo Perindopril Perindopril Tab 4 mg; 30 tablets, blister $4.80 $4.80 Apo Perindopril Pethidine Inj 50 mg per ml, 1 ml ampoule; 5 $5.51 $4.98 DBL Pethidine Hydrochloride (Pfizer) Pethidine Inj 50 mg per ml, 2 ml ampoule; 5 $5.83 $5.12 DBL Pethidine A Page 5 of 15

6 Chemical name subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Hydrochloride (Pfizer) Date of subsidy change Sole Subsidised Supply Poloxamer Oral drops 10%; 30 ml OP bottle $3.78 $3.78 Coloxyl (Aspen) Prednisone Tab 1 mg; 500 tablets, bottle $10.68 $10.68 Apo Prednisone 1 April July 2017 Prednisone Tab 2.5 mg; 500 tablets, bottle $12.09 $12.09 Apo Prednisone 1 April July 2017 Prednisone Tab 5 mg; 500 tablets, bottle $11.09 $11.09 Apo Prednisone 1 April July 2017 Prednisone Tab 20 mg; 500 tablets, bottle $29.03 $29.03 Apo Prednisone 1 April July 2017 Procaine penicillin Inj 1.5 g in 3.4 ml syringe; 5 prefilled syringes $ $ Cilicaine (Aspen) Quetiapine Tab 25 mg; 90 tablets, blister $2.10 $1.79 Quetapel (Mylan) Quetiapine Tab 100 mg; 90 tablets, blister $4.20 $3.45 Quetapel (Mylan) Quetiapine Tab 200 mg; 90 tablets, blister $7.20 $5.75 Quetapel (Mylan) Quetiapine Tab 300 mg; 90 tablets, blister $12.00 $9.60 Quetapel (Mylan) Rifampicin Rifampicin Rifampicin Rizatriptan Cap 150 mg; 100 tablets, blister Cap 300 mg; 100 tablets, blister Oral liq 100 mg per 5 ml; 60 ml bottle Tab orodispersible 10 mg; 30 tablets, blister Sulphadiazine silver Crm 1%; 50 g OP tube $12.30 $10.80 $55.75 $55.75 Rifadin (Sanofi) $ $ Rifadin (Sanofi) $12.00 $12.00 Rifadin (Sanofi) $8.10 $5.26 Rizamelt (Mylan) Flamazine (Smith and Nephew) 1 June September 2017 Temazepam Tab 10 mg; 25 tablets, blister $1.27 $1.27 Normison (Aspen) Testosterone cypionate Inj long acting 100 mg per ml, 10 ml vial; 1 vial $76.50 $76.50 Depo Testosterone (Pfizer) Timolol Eye drops 0.25%; 5 ml OP bottle $1.45 $1.43 Arrow Timolol Timolol Eye drops 0.5%; 5 ml OP bottle $1.45 $1.43 Arrow Timolol A Page 6 of 15

7 Chemical name Tramadol Ursodeoxycholic acid Cap 50 mg; 100 capsules, blister subsidy (and price) New subsidy (and price) $2.50 $2.25 Paste 0.1%; 5 g OP tube $5.33 $5.33 Inj 10 mg per ml, 1 ml ampoule; 5 Inj 40 mg per ml, 1 ml ampoule; 5 Sole supply brand (Supplier) Arrow Tramadol Kenalog in Orabase (Aspen) Date of subsidy change Sole Subsidised Supply $20.80 $20.80 Kenacort A 10 (Aspen) $51.10 $51.10 Kenacort A 40 (Aspen) Crm 0.02%; 100 g OP tube $6.30 $6.30 Aristocort (Aspen) Oint 0.02%; 100 g OP tube $6.35 $6.35 Aristocort (Aspen) Cap 250 mg; 100 capsules, blister $53.40 $37.95 Ursosan (ABM) Vancomycin Inj 500 mg vial; 1 vial $2.64 $2.37 Mylan (Mylan) Zidovudine [AZT] with lamivudine Tab 300 mg with lamivudine 150 mg; 60 tablets, bottle $44.00 $33.00 Alphapharm (Mylan) Hospital pharmaceutical tenders Section H of the Pharmaceutical Schedule 3. Tenders awarded to currently listed pharmaceuticals where no other brand is listed. The decisions were as follows: Chemical Name Acetazolamide Tab 250 mg; 100 tablets, bottle price Acitretin Cap 10 mg; 60 capsules, blister $17.86 $17.86 A Page 7 of 15 Listing Status $17.03 $17.03 Diamox (Arrow) Novatretin (Douglas) Acitretin Cap 25 mg; 60 capsules, blister $41.36 $41.36 Novatretin

8 Chemical Name Alfentanil Inj 0.5 mg per ml, 2 ml ampoule; 10 price $39.07 $34.38 Amlodipine Tab 2.5 mg; 100 tablets, bottle $2.21 $1.72 Amlodipine Tab 5 mg; 250 tablets, bottle $5.04 $3.33 Amlodipine Tab 10 mg; 250 tablets, bottle $7.21 $4.40 (Douglas) Hameln (Max Health) Apo Amlodipine Apo Amlodipine Apo Amlodipine A Page 8 of 15 Listing Status Amorolfine Nail soln 5%; 5 ml bottle $19.95 $15.95 MycoNail (AFT) Amoxicillin Inj 250 mg vial; 10 vials $10.67 $10.67 Ibiamox (Douglas) Amoxicillin Inj 500 mg vial; 10 vials $12.41 $12.41 Ibiamox (Douglas) Amoxicillin Inj 1 g vial; 10 vials $17.29 $17.29 Ibiamox (Douglas) Amoxicillin with clavulanic acid Tab 500 mg with clavulanic acid 125 mg; 20 tablets, blister $1.95 $1.88 Augmentin (GlaxoSmithKline) 1% 1 August October 2017 Atropine sulphate Eye drops 1%; 15 ml bottle $17.36 $17.36 Atropt (Aspen) Benzylpenicillin sodium [Penicillin G] Betahistine di Bupivacaine Bupivacaine Bupropion Inj 600 mg (1 million units) vial; 10 vials $10.35 $10.35 Sandoz (Novartis) Tab 16 mg; 84 tablets, blister $4.95 $2.89 Vergo 16 (Mylan) Inj 2.5 mg per ml, 100 ml bag; 5 bags Inj 5 mg per ml, 4 ml ampoule; 5 Tab modified release 150 mg; 30 tablets, blister $ $ Marcain (Aspen) $50.00 $50.00 $11.00 $11.00 Calcipotriol Oint 50 mcg per g; 100 g tube $45.00 $45.00 Marcain Isobaric (Aspen) Zyban (GlaxoSmithKline) Daivonex (Leo Pharma) 1% 1 May July 2017 Cefazolin Inj 500 mg vial; 5 vials $3.99 $3.39 AFT (AFT) Cefazolin Inj 1 g vial; 5 vials $3.38 $3.29 AFT (AFT)

9 Chemical Name price Cefotaxime Inj 1 g vial; 10 vials $17.10 $14.60 DBL Cefotaxime (Pfizer) A Page 9 of 15 Listing Status Ciprofloxacin Tab 250 mg; 28 tablets blister $1.75 $1.45 Cipflox (Mylan) Ciprofloxacin Tab 500 mg; 28 tablets, blister $2.00 $1.99 Cipflox (Mylan) Ciprofloxacin Tab 750 mg; 28 tablets, blister $3.75 $3.15 Cipflox (Mylan) Cyproterone acetate with ethinyloestradiol Tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tablets; 168 tablets, blister Darunavir Tab 400 mg; 60 tablets, bottle $ $ Darunavir Tab 600 mg; 60 tablets, bottle $1, $ $5.36 $4.67 Ginet (Rex Medical) Prezista (Janssen Cilag) Prezista (Janssen Cilag) Dexmedetomidine Inj 100 mcg per ml, 2 ml vial; 5 vial $ $ Precedex (Pfizer) Docusate sodium Tab 50 mg; 100 tablets, bottle $2.31 $2.31 Coloxyl (Aspen) Docusate sodium Donepezil Donepezil Tab 120 mg; 100 tablets, bottle Tab 5 mg; 90 tablets, blister $5.48 $4.34 Tab 10 mg; 90 tablets, blister $10.51 $6.64 Doxazosin Tab 2 mg; 500 tablets, bottle $6.75 $6.75 Doxazosin Tab 4 mg; 500 tablets, bottle $9.67 $9.09 Fusidic acid Tab 250 mg; 12 tablets, blister $34.50 $34.50 $3.13 $3.13 Coloxyl (Aspen) Donepezil REX (Rex Medical) Donepezil REX (Rex Medical) Apo Doxazosin Apo Doxazosin Fucidin (Leo Pharma) Gliclazide Tab 80 mg; 500 tablets, bottle $11.50 $10.29 Glizide (Mylan) Hydrocortisone Powder; 25 g bottle $59.50 $49.95 ABM (ABM) Hydrocortisone and paraffin liquid and Lotn 1% with paraffin liquid 15.9% and lanolin 0.6%; 250 ml bottle $10.57 $10.57 DP Lotion HC (Douglas)

10 Chemical Name lanolin Isosorbide mononitrate Tab long acting 60 mg; 90 tablets, blister price A Page 10 of 15 Listing Status $8.49 $8.29 Duride (Mylan) Ketoconazole Shampoo 2%; 100 ml bottle $2.99 $2.99 Sebizole (Douglas) Lidocaine [lignocaine] with adrenaline and tetracaine Lopinavir with ritonavir Soln 4% with adrenaline 0.1% and tetracaine 0.5%, 5 ml syringe; 1 prefilled syringe Tab 200 mg with ritonavir 50 mg; 120 tablets, bottle Losartan potassium Tab 12.5 mg; 84 tablets, blister $1.55 $1.39 Losartan potassium Tab 25 mg; 84 tablets, blister $1.90 $1.63 Losartan potassium Tab 50 mg; 84 tablets, blister $2.25 $2.00 Losartan potassium Tab 100 mg; 84 tablets, blister $2.60 $2.31 Magnesium sulphate Inj 2 mmol per ml, 5 ml ampoule; 10 Methotrexate Inj 100 mg per ml, 50 ml vial; 1 vial $99.99 $79.99 Miconazole nitrate Morphine sulphate Morphine sulphate Naltrexone Vaginal crm 2% with applicator; 40 g tube Tab immediate release 10 mg; 10 tablets, blister Tab immediate release 20 mg; 10 blister $17.50 $17.50 Topicaine (Biomed) $ $ Kaletra (AbbVie) Losartan Actavis Losartan Actavis Losartan Actavis Losartan Actavis 1% 1 September November % 1 September November % 1 September November % 1 September November 2017 $12.65 $10.21 DBL (Pfizer) Methotrexate Ebewe (Novartis) $3.95 $3.88 Micreme (Mylan) $2.80 $2.80 $5.52 $5.52 Tab 50 mg; 30 blister $ $ Sevredol (MundiPharma) Sevredol (MundiPharma) Naltraccord

11 Chemical Name price A Page 11 of 15 Listing Status Olanzapine Tab 2.5 mg; 28 tablets, blister $0.75 $0.64 Zypine (Mylan) Olanzapine Tab 5 mg; 28 tablets, blister $1.65 $1.15 Zypine (Mylan) Olanzapine Tab 10 mg; 28 tablets, blister $2.55 $1.65 Zypine (Mylan) Olanzapine Olanzapine Tab orodispersible 5 mg; 28 tablets, blister Tab orodispersible 10 mg; 28 tablets, blister $1.75 $1.25 Zypine ODT (Mylan) $3.05 $2.05 Zypine ODT (Mylan) Oxazepam Tab 10 mg; 100 tablets, bottle $6.17 $6.17 Ox Pam (Douglas) Oxazepam Tab 15 mg; 100 tablets, bottle $8.53 $8.53 Ox Pam (Douglas) Pamidronate disodium Pamidronate disodium Pamidronate disodium Inj 3 mg per ml, 10 ml vial; 1 vial $6.80 $5.98 Pamisol (Pfizer) Inj 6 mg per ml, 10 ml vial; 1 vial $13.20 $15.02 Pamisol (Pfizer) Inj 9 mg per ml, 10 ml vial; 1 vial $19.20 $17.05 Pamisol (Pfizer) Perindopril Tab 2 mg; 30 tablets, blister $3.75 $3.75 Perindopril Tab 4 mg; 30 tablets, blister $4.80 $4.80 Pethidine Pethidine Inj 50 mg per ml, 1 ml ampoule; 5 Inj 50 mg per ml, 2 ml ampoule; 5 $5.51 $4.98 $5.83 $5.12 Apo Perindopril Apo Perindopril DBL Pethidine Hydrochloride (Pfizer) DBL Pethidine Hydrochloride (Pfizer) Poloxamer Oral drops 10%; 30 ml bottle $3.78 $3.78 Coloxyl (Aspen) Prednisone Tab 1 mg; 500 tablets, bottle $10.68 $10.68 Prednisone Tab 2.5 mg; 500 tablets, bottle $12.09 $12.09 Apo Prednisone Apo Prednisone

12 Chemical Name price Prednisone Tab 5 mg; 500 tablets, bottle $11.09 $11.09 Prednisone Tab 20 mg; 500 tablets, bottle $29.03 $29.03 Procaine penicillin Inj 1.5 g in 3.4 ml syringe; 5 prefilled syringes Apo Prednisone Apo Prednisone A Page 12 of 15 Listing Status $ $ Cilicaine (Aspen) Quetiapine Tab 25 mg; 90 tablets, blister $2.10 $1.79 Quetapel (Mylan) 1% 1 May October 2017 Quetiapine Tab 100 mg; 90 tablets, blister $4.20 $3.45 Quetapel (Mylan) Quetiapine Tab 200 mg; 90 tablets, blister $7.20 $5.75 Quetapel (Mylan) Quetiapine Tab 300 mg; 90 tablets, blister $12.00 $9.60 Quetapel (Mylan) Rifampicin Rifampicin Rifampicin Cap 150 mg; 100 capsules, blister Cap 300 mg; 100 capsules, blister Oral liq 100 mg per 5 ml; 60 ml bottle $55.75 $55.75 Rifadin (Sanofi) $ $ Rifadin (Sanofi) $12.00 $12.00 Rifadin (Sanofi) Rifampicin Inj 600 mg vial; 1 vial $ $ Rifadin (Sanofi) Rizatriptan Tab orodispersible 10 mg; 30 tablets, blister Sulphadiazine silver Crm 1%; 50 g tube $12.30 $10.80 $8.10 $5.26 Rizamelt (Mylan) Flamazine (Smith and Nephew) Temazepam Tab 10 mg; 25 tablets, blister $1.27 $1.27 Normison (Aspen) Testosterone cypionate Inj long acting 100 mg per ml, 10 ml vial; 1 vial $76.50 $76.50 Timolol Eye drops 0.25%; 5 ml bottle $1.45 $1.43 Timolol Eye drops 0.5%; 5 ml bottle $1.45 $1.43 Tramadol Cap 50 mg; 100 capsules, blister $2.50 $2.25 Depo Testosterone (Pfizer) Arrow Timolol Arrow Timolol Arrow Tramadol

13 Chemical Name Ursodeoxycholic acid price Paste 0.1%; 5 g tube $5.33 $5.33 Kenalog in Orabase (Aspen) Listing Status Crm 0.02%; 100 g tube $6.30 $6.30 Aristocort (Aspen) Oint 0.02%; 100 g tube $6.35 $6.35 Aristocort (Aspen) Inj 10 mg per ml, 1 ml ampoule; 5 Inj 40 mg per ml, 1 ml ampoule; 5 Cap 250 mg; 100 capsules, blister $20.80 $20.80 $51.70 $51.10 Kenacort A 10 (Aspen) Kenacort A 40 (Aspen) $53.40 $37.95 Ursosan (ABM) Vancomycin Inj 500 mg vial; 1 vial $2.64 $2.37 Mylan (Mylan) Zidovudine [AZT] with lamivudine Tab 300 mg with lamivudine 150 mg; 60 tablets, bottle $44.00 $33.00 Alphapharm (Mylan) 4. Tenders awarded to pharmaceuticals where at least one other brand is listed. The decisions were as follows: Chemical Name price Listing Status affected by delisting Remifentanil Inj 1 mg vial; 5 vials $10.00 $13.95 Remifentanil AFT (AFT) 1% 1 August October 2017 Ultiva (GSK) Remifentanil Inj 2 mg vial; 5 vials $18.00 $19.95 Remifentanil AFT (AFT) 1% 1 August October 2017 Ultiva (GSK) Glycerol Liquid; 500 ml bottle N/A $3.28 healthe Glycerol BP Liquid (Jaychem) Paracetamol with codeine Tab paracetamol 500 mg with codeine phosphate 8 mg; 1,000 tablets, blister N/A $18.21 Paracetamol + Codeine (Relieve) (Mylan) ABM (ABM), 2,000 ml bottle Relieve (Mylan) 100 tablets, blister A Page 13 of 15

14 Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Status PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Status for the following products listed in the 2016/17 Invitation to Tender, d 3 November 2016: Invitation to Tender Chemical Name Line Item Chemical Name Line Item Amphotericin B Inj 50 mg (non liposomal) Loteprednol etabonate Eye drops 0.5% ( size 5 ml or less) Atovaquone with proguanil Atovaquone with proguanil Tab 250 mg with proguanil 100 mg Tab 62.5mg with proguanil 25 mg (Paediatric) Nifedipine Nifedipine Cap 5 mg Baclofen Tab 10 mg Nitrazepam Tab 5 mg Tab long acting 20 mg Brimonidine Gel 0.5% Norfloxacin Tab 400 mg Calcitonin Demeclocycline Demeclocycline Flucytosine Haloperidol decanoate Haloperidol decanoate Imipenem with cilastatin Iron polymaltose Inj 100 iu per ml, 1 ml Cap 150 mg Cap 300 mg Cap 500 mg Inj 100 mg per ml, 1 ml ampoule Inj 50 mg per ml, 1 ml ampoule Inj 500 mg with cilastatin 500 mg Inj 50 mg per ml, 2 ml Paraffin liquid with wool fat liquid 2a 2a 2a 2b 2b 2b 2b Eye oint 3% with wool fat liq 3% Inj 135 mcg Inj 135 mcg with ribavirin Inj 180 mcg with ribavirin Inj 50 mcg Inj 80 mcg Inj 100 mcg inj 120 mcg A Page 14 of 15

15 Chemical Name Line Item Chemical Name Line Item 2b 2b with ribavirin 2b with ribavirin 2b with ribavirin 2b with ribavirin 2b with ribavirin Inj 150 mcg Penicillamine Tab 250 mg Inj 50 mcg with ribavirin Primidone Tab 25 mg Inj 80 mcg with ribavirin Primidone Tab 50 mg Inj 100 mcg with ribavirin Quinine di Inj 600 mg Inj 120 mcg with ribavirin Quinine sulphate Tab 300 mg Inj 150 mcg with ribavirin Sodium nitroprusside Urinary Ketone Test strip Sumatriptan Nasal spray Penicillamine Tab 125 mg Ticarcillin with clavulanic acid Inj 3 g with clavulanic acid 0.1 mg vial For products included in the 2014/15, 2015/16 and 2016/17 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any ups regarding such tender products as decisions are made. If you have any queries regarding this notification, please contact PHARMAC on A Page 15 of 15

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 28 February 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2015/16 Invitation to Tender, d 6 November 2015 and

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 April 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 April 2014 30 April 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 May 2014 30 May 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October

More information

July 2017 Section H of the Pharmaceutical Schedule Update

July 2017 Section H of the Pharmaceutical Schedule Update 16 June 2017 July 2017 Section H of the Pharmaceutical Schedule Update The Section H Update summary is provided to DHB hospital pharmacists as a preview of the changes that will be announced in the next

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014 28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes 30 June 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 19 December 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 19 December 2014 19 December 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012

More information

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 31 August 2016 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2015/16 Invitation to Tender, d 6 November

More information

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 28 April 2017 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2016/17 Invitation to Tender, d 3 November

More information

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes 29 February 2016 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2014/15 Invitation to Tender, d 6 November 2014, and

More information

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014

TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014 31 October 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and

More information

Release of the 2013/14 Invitation to Tender

Release of the 2013/14 Invitation to Tender 07 November 2013 Release of the 2013/14 Invitation to Tender The 2013/14 Invitation to Tender (2013/14 ITT) has been distributed today via the electronic tender (etender) system. If you do not receive

More information

2007/08 Tender. Current Subsidy and price. Bendrofluazide Tab 5 mg; 500 tablets, bottle $21.50 $11.75 Arrow-Bendrofluazide (Arrow)

2007/08 Tender. Current Subsidy and price. Bendrofluazide Tab 5 mg; 500 tablets, bottle $21.50 $11.75 Arrow-Bendrofluazide (Arrow) 31 March 2010 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Status for some of the products included in the

More information

Section H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Section H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML) The Hospital Medicines List (HML) Section H for Hospital Management Agency Pharmaceuticals Update Update effective 1 August 2014 New Zealand Pharmaceutical Schedule Effective 1 July 2013 Cumulative for

More information

Release of the 2017/18 Invitation to Tender

Release of the 2017/18 Invitation to Tender 2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s

More information

Price Changes advised by Pharmac As at 12 June 2015

Price Changes advised by Pharmac As at 12 June 2015 s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule % + or - 01 Jun 15 31 Oct

More information

(price) Underlined indicates tender winning product now available at new subsidy $5.62 $4.89. $2.35 (Manuf price $5.26) $2.59

(price) Underlined indicates tender winning product now available at new subsidy $5.62 $4.89. $2.35 (Manuf price $5.26) $2.59 Sole Supply - Pending Changes Quick Reference 1 *** Sorted by Sole *** Chemical Type, Strength, Pack Size Pharmacode Current New Tender of New of Sole Supply and Reference Start Thiamine hydrochloride

More information

Your DISPENSARY Tips as at 11 March 2016

Your DISPENSARY Tips as at 11 March 2016 This information has been prepared to provided some essential buying tips for the upcoming months. It is designed to be used in conjunction with the full text documents contained within the Pharmac Updates

More information

Your DISPENSARY Tips as at 26 November 2015

Your DISPENSARY Tips as at 26 November 2015 This information has been prepared to provided some essential buying tips for the upcoming months. It is designed to be used in conjunction with the full text documents contained within the Pharmac Updates

More information

Update New Zealand Pharmaceutical Schedule Effective 1 September 2017

Update New Zealand Pharmaceutical Schedule Effective 1 September 2017 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2017 Contents Summary of PHARMAC decisions effective 1 September 2017... 3 New listings... 5 Temozolomide

More information

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 August 2018

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 August 2018 Pharmaceutical Management Agency Section H Update for Hospital Pharmaceuticals Effective 1 August 2018 Contents Summary of decisions effective 1 August 2018... 3 Section H changes to Part II... 8 Index...

More information

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML) The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update effective 1 May 2014 New Zealand Cumulative for April and May 2014 Pharmaceutical

More information

Price Changes advised by Pharmac As at 02 July 2015

Price Changes advised by Pharmac As at 02 July 2015 s advised by Pharmac New to be available ex Manufacturer from 12th of preceding month. From Wholesale from date of supplier support which could vary. Product Supplier Schedule 01 Jul 15 29 May 15 Irinotecan

More information

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML) The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update effective 1 June 2014 New Zealand Cumulative for April, May and June 2014 Pharmaceutical

More information

Release of the 2014/15 Invitation to Tender

Release of the 2014/15 Invitation to Tender 6 November 2014 Release of the 2014/15 Invitation to Tender The 2014/15 Invitation to Tender (2014/15 ITT) has been distributed today. Please note that the Electronic Portal will not be available until

More information

Approval of proposals for various pharmaceuticals

Approval of proposals for various pharmaceuticals 9 August 2010 Approval of proposals for various pharmaceuticals PHARMAC is pleased to announce the approval of proposals for pharmaceuticals in several therapeutic groups which aim to address some issues

More information

Rajasthan Medical Services Corporation Limited, Jaipur

Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV

More information

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019 This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 15 th February 2019 Product

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2014 Contents Summary of PHARMAC decisions effective 1 September 2014... 3 Erythropoietin changes to subsidy...

More information

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019 This table contains information on shortages of human medicines notified to the Health Products Regulatory Authority that have been resolved in the last 6 months. Table updated 26 th February 2019 Product

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Abiraterone acetate (Zytiga) new listing... 5 Actavis

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 4 What s changing?... 6 Metoprolol succinate

More information

Kern Pharma Portfolio 2014

Kern Pharma Portfolio 2014 Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN

More information

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5 Abiraterone Tablet 250 mg Q4 2015 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Q4 2014 Alendronic Acid Tablet 70 mg Available Amisulpride Tablet 50 ; 100 ; 200 ; 400 mg Available

More information

Update New Zealand Pharmaceutical Schedule Effective 1 May 2016

Update New Zealand Pharmaceutical Schedule Effective 1 May 2016 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Sumatriptan update on Sumatriptan injections... 4

More information

To: Medical Groups, DHB Hospital Pharmacies and Interested Parties

To: Medical Groups, DHB Hospital Pharmacies and Interested Parties 24 September 2008 To: Medical Groups, DHB Hospital Pharmacies and Interested Parties CONSULTATION ON TENDER OF CERTAIN PHARMACEUTICALS ALL RESPONSES DUE BY 5PM, WEDNESDAY 5 NOVEMBER 2008 In accordance

More information

Update New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016

Update New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April 2016 Cumulative for January, February, March and April 2016 Contents Summary of PHARMAC decisions effective

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2015 Cumulative for September and October 2015 Contents Summary of PHARMAC decisions effective 1 October

More information

Update New Zealand Pharmaceutical Schedule Effective 1 February 2018 Cumulative for January and February 2018

Update New Zealand Pharmaceutical Schedule Effective 1 February 2018 Cumulative for January and February 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February Cumulative for January and February Contents Summary of PHARMAC decisions effective 1 February... 3 New

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 February Cumulative for December 2014 and January Contents Summary of PHARMAC decisions effective 1 February... 3

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2015 Cumulative for September, October and November 2015 Contents Summary of PHARMAC decisions effective

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2013 Cumulative for September, October, November and December 2013 Contents Summary of PHARMAC decisions

More information

Approval of Multiple Diabetes Management Products and Mesalazine proposals

Approval of Multiple Diabetes Management Products and Mesalazine proposals 8 June Approval of Multiple Diabetes Management Products and Mesalazine proposals PHARMAC is pleased to announce the approval of five agreements in relation to funding of blood glucose, blood glucose diagnostic

More information

Update New Zealand Pharmaceutical Schedule Effective 1 January 2019

Update New Zealand Pharmaceutical Schedule Effective 1 January 2019 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 4 News Stories January Update... 6 New listings...

More information

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6 Abiraterone Tablet 250 mg Q4 2016 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Available Alendronic Acid Tablet 70 mg Available Amikacin Solution for injection 50 mg/ml; 125mg/ml;

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2014 Cumulative for May, June and July 2014 Contents Summary of PHARMAC decisions effective 1 July 2014... 3

More information

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M % June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has

More information

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015 Calgary Long Term Care Formulary Pharmacy & Therapeutics February 2015 Highlights http://www.albertahealthservices.ca/4070.aspx 1 Contents February 2016... 3 Added Product(s)... 3 Not Listed, Delisted

More information

NIT 97 - APPROVED DRUG LIST

NIT 97 - APPROVED DRUG LIST 1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin

More information

Update New Zealand Pharmaceutical Schedule Effective 1 May 2018

Update New Zealand Pharmaceutical Schedule Effective 1 May 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 New tender listings for 1 May... 4 New listings...

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 August 2014 Cumulative for May, June, July, and August 2014 Contents Summary of PHARMAC decisions effective 1 August

More information

Update New Zealand Pharmaceutical Schedule Effective 1 September 2016

Update New Zealand Pharmaceutical Schedule Effective 1 September 2016 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2016 Contents Summary of PHARMAC decisions effective 1 September 2016... 3 What s changing?... 5 Pembrolizumab

More information

Section H. Pharmaceuticals. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 November 2014

Section H. Pharmaceuticals. Pharmaceutical Schedule. Effective 1 July for Hospital. Update effective 1 November 2014 The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update effective 1 November 2014 Update New Cumulative Zealand for August, September, October and

More information

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 December 2018

Pharmaceutical Management Agency. Section H Update. for Hospital. Pharmaceuticals. Effective 1 December 2018 Pharmaceutical Management Agency Section H Update for Hospital Pharmaceuticals Effective 1 December 2018 Contents Summary of decisions effective 1 December 2018... 3 Section H changes to Part II... 4 Index...

More information

DT Description Price Category Price change

DT Description Price Category Price change Tariff T Watch October 2014 Readers are no doubt aware of this quarter's bad news for primary care prescribing allocations: NHS England has d the remuneration mechanism for community pharmacies gaining

More information

Update. New Zealand Pharmaceutical Schedule. Effective 1 November Cumulative for September, October and November 2018

Update. New Zealand Pharmaceutical Schedule. Effective 1 November Cumulative for September, October and November 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2018 Cumulative for September, October and November 2018 Contents Summary of PHARMAC decisions effective

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2013 Cumulative for September and October 2013 Contents Summary of PHARMAC decisions effective 1 October

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2015 Cumulative for May, June and July 2015 Contents Summary of PHARMAC decisions effective 1 July 2015... 3

More information

Update New Zealand Pharmaceutical Schedule

Update New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April Cumulative for January, February, March and April Contents Summary of PHARMAC decisions effective 1 April...

More information

Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing

Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing Infections therapeutic group PTAC and Subcommittee of PTAC minutes are

More information

Update New Zealand Pharmaceutical Schedule Effective 1 December 2016 Cumulative for September, October, November and December 2016

Update New Zealand Pharmaceutical Schedule Effective 1 December 2016 Cumulative for September, October, November and December 2016 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2016 Cumulative for September, October, November and December 2016 Contents Summary of PHARMAC decisions

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2013 Cumulative for May, June and July 2013 Contents Summary of PHARMAC decisions effective 1 July 2013... 3

More information

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017 Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

Update New Zealand Pharmaceutical Schedule Effective 1 March 2017 Cumulative for January, February and March 2017

Update New Zealand Pharmaceutical Schedule Effective 1 March 2017 Cumulative for January, February and March 2017 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March Cumulative for January, February and March Contents Summary of PHARMAC decisions effective 1 March... 3 What

More information

Medicines Formulary BNF Section 4 Central Nervous System

Medicines Formulary BNF Section 4 Central Nervous System Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam

More information

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017 Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 September 2013 Contents Summary of PHARMAC decisions effective 1 September 2013... 3 New brand of enalapril maleate

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 October 2014 Cumulative for September and October 2014 Contents Summary of PHARMAC decisions effective 1 October

More information

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets

More information

Advance Notification of Amendments to the August 2018 Drug Tariff

Advance Notification of Amendments to the August 2018 Drug Tariff Advance Notification of Amendments to the August 2018 Drug Tariff ADDITIONS Zero Discount Brivaracetam 100mg tablets Brivaracetam 25mg tablets Brivaracetam 50mg tablets Brivaracetam 75mg tablets Maraviroc

More information

Update New Zealand Pharmaceutical Schedule Effective 1 July 2018 Cumulative for May, June and July 2018

Update New Zealand Pharmaceutical Schedule Effective 1 July 2018 Cumulative for May, June and July 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 July 2018 Cumulative for May, June and July 2018 Contents Summary of PHARMAC decisions effective 1 July 2018... 4

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2011 Cumulative for September, October, November and December 2011 Section H for December 2011 Contents

More information

Update New Zealand Pharmaceutical Schedule

Update New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2017 Cumulative for September, October, November and December 2017 Contents Summary of PHARMAC decisions

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March Cumulative for January, February and March Section H cumulative for December 2011, January, February and March

More information

Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin)

Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) 14 July 2015 Proposal relating to the funding of TNF inhibitors (Humira and Enbrel) and gabapentin (Neurontin) PHARMAC is seeking feedback on a proposal relating to the funding of the TNF-inhibitor medicines

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May Contents Summary of PHARMAC decisions effective 1 May... 3 Diabetes Nurses Prescribers... 4 Tacrolimus brand

More information

Advance Notification of Amendments to the December 2018 Drug Tariff

Advance Notification of Amendments to the December 2018 Drug Tariff Advance Notification of Amendments to the December 2018 Drug Tariff ADDITIONS Zero Discount Fondaparinux sodium solution for injection pre-filled (ALL) FreeStyle Libre Sensor Oxygen CD cylinder Oxygen

More information

Update New Zealand Pharmaceutical Schedule

Update New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 December 2018 Cumulative for September, October, November and December 2018 Contents Summary of PHARMAC decisions

More information

No. Description Packing UOM

No. Description Packing UOM Republic of the Philippines PITC Pharma, Inc. Bids and Awards Committee INVITATION TO BID VARIOUS GENERIC & ONCOLOGY MEDICINES, MEDICAL DEVICE & SUPPLIES (PROJECT REF. NO. BAC/GOODS 2016-02-002) The PITC

More information

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole

More information

2017 Formulary Changes Year to Date

2017 Formulary Changes Year to Date 2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or

More information

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope LIST OF PRODUCTS S.No Name Form Pharmacope ia Strength Therapeutic Segment ECTIONS DRY POWDER ECTIONS & LIQUID ECTIONS 1 a b Arteether 75mg/ml 150 mg/2ml & 225 mg/3ml 2 Amikacin Sulfate IP/ 100/250/500

More information

PBS PRICE INCREASES - AUGUST 2014 SCHEDULE

PBS PRICE INCREASES - AUGUST 2014 SCHEDULE Price increase review - general PBS benzylpenicillin 600 mg injection, 1 x 600 mg vial 1775K, 3398W, BenPen 3.84 4.38 3486L benzylpenicillin 3 g injection, 1 x 3 g vial 2647H, 3399X, BenPen 6.60 7.55 3487M

More information

Update New Zealand Pharmaceutical Schedule Effective 1 January 2018

Update New Zealand Pharmaceutical Schedule Effective 1 January 2018 Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 3 New tender listings for 1 January... 5 New

More information

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M. April 2018 The usual quarterly of Category M prices Another set of similar comments as I made in January: significant increases in many lines which have been subject to price concessions but even more

More information

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague,

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, Supporting document for NPSA Injectables Patient Safety Alert Attached is a document

More information

AETNA BETTER HEALTH January 2017 Formulary Change(s)

AETNA BETTER HEALTH January 2017 Formulary Change(s) AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10

More information

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Section H. Pharmaceuticals. New Zealand. Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML) The Hospital Medicines List (HML) Section H for Hospital Pharmaceuticals Pharmaceutical Management Agency Update Update Effective 1 November 2013 New Zealand Cumulative for July, August, September, October

More information

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada,

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada, 1 Appendix Commentary 515 Appendix: Assessing Canada s Drug Shortage Problem Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada, 2013 16 Drug Name Dosage Therapeutic

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 January Contents Summary of PHARMAC decisions effective 1 January... 3 Removal of Special Authority from Seretide...

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 November 2012 Cumulative for September, October and November 2012 Section H cumulative for August, September, October

More information

$55. today. Register. New Zealand Pharmaceutical Schedule. Effective 1 August www. schedule. co.nz. Sign up. Only

$55. today. Register. New Zealand Pharmaceutical Schedule. Effective 1 August www. schedule. co.nz. Sign up. Only Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 August 2012 Cumulative for May, June, July and August 2012 Section H for August 2012 $55 Only annually for hard copy

More information

Pip Description Item Size EAN ACETAZOLAMIDE TABS 250MG ADENOSINE INJECTION 30MG/10ML MPI 10ML

Pip Description Item Size EAN ACETAZOLAMIDE TABS 250MG ADENOSINE INJECTION 30MG/10ML MPI 10ML Pip Description Item Size EAN 112-6895 ACETAZOLAMIDE TABS 250MG 112 5060010283911 118-7376 ADENOSINE INJECTION 30MG/10ML MPI 10ML 6 5099602996281 118-7384 ADENOSINE INJECTION 3MG/ 1ML MPI 2ML 6 5099602996274

More information

Pip Description Item Size EAN 6999 DELTASTAB INJ 25MG/1ML APRESOLINE AMP 20MG AUREOCORT OINT 15G

Pip Description Item Size EAN 6999 DELTASTAB INJ 25MG/1ML APRESOLINE AMP 20MG AUREOCORT OINT 15G Pip Description Item Size EAN 6999 DELTASTAB INJ 25MG/1ML 10 5021730017613 15859 APRESOLINE AMP 20MG 5 5021730005740 21717 AUREOCORT OINT 15G 5021691164753 29033 SLOW TRASICOR TAB 160MG 28 5060064170410

More information

New Zealand Pharmaceutical Schedule

New Zealand Pharmaceutical Schedule Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 April 2013 Cumulative for January, February, March and April 2013 Section H for April 2013 Contents Summary of PHARMAC

More information

REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY

REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY 9 November 2016 Dear Supplier REQUEST FOR PROPOSALS SUPPLY OF NICOTINE REPLACEMENT THERAPY PHARMAC invites proposals for the supply of nicotine replacement therapy (NRT) (including, but not limited to,

More information

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No. LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml

More information